Cargando…
Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier within the core of tumors by constricting the blood vessels and forming clots, leading to poor intratumoral distribution of anticancer drugs. Our group previously developed a microplasmin-based thrombolytic...
Autores principales: | Seo, Junyoung, Do Yoo, Jae, Kim, Minseong, Shim, Gayong, Oh, Yu-Kyoung, Park, Rang-Woon, Lee, Byungheon, Kim, In-San, Kim, Soyoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569170/ https://www.ncbi.nlm.nih.gov/pubmed/34667244 http://dx.doi.org/10.1038/s12276-021-00688-7 |
Ejemplares similares
-
Designed ferritin nanocages displaying trimeric TRAIL and tumor-targeting peptides confer superior anti-tumor efficacy
por: Yoo, Jae Do, et al.
Publicado: (2020) -
THE LYSIS IN RABBITS OF INTRAVASCULAR BLOOD CLOTS BY THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM (STREPTOKINASE)
por: Johnson, Alan J., et al.
Publicado: (1952) -
Mechanical Stability and Fibrinolytic Resistance of Clots Containing Fibrin, DNA, and Histones
por: Longstaff, Colin, et al.
Publicado: (2013) -
Endotoxin enhances the fibrinolytic activity of monocytes incorporated in a fibrin clot
por: Grosjean, A, et al.
Publicado: (2005) -
Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts
por: Zhalyalov, Ansar S., et al.
Publicado: (2017)